Cardiovascular Disease Doctors in Baytown, TX Accepting Medicare

7 Cardiovascular Disease doctors found. Showing 1 - 7

Dr. Rashid M Siddiqi, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1602 W Baker Rd, Ste A, Baytown, TX 77521 Phone: 281-428-4024    Fax: 281-428-4026

Zohair S Raza, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4201 Garth Rd Ste 107, Baytown, TX 77521 Phone: 954-882-5981

Omar Fayez Hadidi, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4301 Garth Rd Ste 101, Baytown, TX 77521 Phone: 281-422-3364    Fax: 281-422-6864

Gholamreza Khoshnevis, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4002 Garth Rd Ste 110, Baytown, TX 77521 Phone: 713-804-3278    Fax: 888-571-4434

Dr. Nadia Fida, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4201 Garth Rd Ste 318, Baytown, TX 77521 Phone: 281-837-7587

Dr. Sarma S Challa, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4002 Garth Rd, Suite 100, Baytown, TX 77521 Phone: 281-420-2391

Dr. Olufolahan Carrena, M.D Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 4401 Garth Rd, Baytown, TX 77521 Phone: 281-837-7587

News Archive

Discovery highlights need to improve patient education about genomics

An overwhelming majority of people with incurable cancer want to hear findings from DNA sequencing of their own tumors and normal cells, and to learn how those results may affect their health and treatment options, Dana Farber Cancer Institute scientists report.

Boehringer Ingelheim LUX-Lung 8 trial reveals afatinib better than erlotinib to treat SCC of the lung

Boehringer Ingelheim today announced The Lancet Oncology has published results from the LUX-Lung 8 trial. LUX-Lung 8 is the largest, prospective Phase III head-to-head trial directly comparing two EGFR-directed treatments.

Itamar-Medical's WatchPAT technology chosen as one of The Top 10 Medical Innovations for 2010

Itamar-Medical's WatchPAT technology has been selected to The Top 10 Medical Innovations for 2010 at the seventh annual Cleveland Clinic Medical Innovation Summit. In developing the Top 10, Cleveland Clinic enlisted the expertise of AlixPartners, LLP, an independent international management advisory firm in order to develop a consensus perspective on the Top 10 Medical Innovations for 2010.

Study finds abdominal fat as a risk factor for osteoporosis, bone loss in women

For years, it was believed that obese women were at lower risk for developing osteoporosis, and that excess body fat actually protected against bone loss. However, a study presented today at the annual meeting of the Radiological Society of North America (RSNA) found that having too much internal abdominal fat may, in fact, have a damaging effect on bone health.

Read more Medical News

› Verified 3 days ago